Cagrilintide

Cagrilintide Research Material — Buy Cagrilintide (Long-Acting Amylin Analog) (≥97% Purity)

Cagrilintide is a long-acting amylin receptor agonist, chemically stabilized via fatty-acid acylation (the same conjugation strategy used in long-acting GLP-1 research materials) to extend its research half-life. It is one of the most closely studied amylin analogs in current metabolic research, frequently investigated in combination with GLP-1 receptor agonists.

Certificate of Analysis

Mechanism of Action

Cagrilintide activates amylin receptors in the area postrema and hindbrain, signaling pathways associated with satiety, slowed gastric emptying, and reduced food intake in preclinical models. Amylin and GLP-1 signaling pathways are complementary rather than overlapping, which is why co-agonism research (cagrilintide with GLP-1-class compounds) is a major current focus in appetite-regulation pharmacology.

Research Applications

• Amylin receptor pharmacology and appetite regulation studies
• Energy balance and satiety signaling research
• Gastric emptying rate models
• GLP-1/amylin co-agonism and combination protocol research
• Obesity and body-weight regulation preclinical models

Specifications

• Chemical Name: Cagrilintide (Long-Acting Amylin Analog)
• CAS Number: 2138861-62-4
• Molecular Formula: Complex fatty-acid conjugated research material (proprietary modified sequence)
• Molecular Weight: ≈4.5 kDa
• Sequence: Acylated amylin analog — full sequence proprietary
• Purity: ≥97% (HPLC verified)
• Form: Lyophilized powder
• Available Sizes: 5mg, 10mg

Storage & Handling

Store lyophilized Cagrilintide at −20°C, protected from light and moisture. Once reconstituted with Reconstitution Solution, store at 4°C and use within 28 days. All handling should be performed under sterile laboratory conditions by trained research personnel.

For in-vitro laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or medicinal product.